Market Trends Bristol Myers Squibb receives positive CHMP opinion for hepatocellular carcinoma treatmentBy admin8996erT0allJanuary 31, 2025 Drew Angerer/Getty Images News Bristol Myers Squibb (NYSE:BMY) announced Friday that an expert panel of the EU drug regulator, the…